Epigenetic and microenvironmental regulation of dormant disseminated cancer

休眠播散性癌症的表观遗传学和微环境调控

基本信息

项目摘要

SUMMARY: The majority of HNSCC patients die from local recurrences and/or metastasis that can occur early, or many years after primary tumor removal. This can be due to disseminated tumor cells (DTCs) remaining dormant in patients. DTCs can be detected in the bone marrow (BM), but rarely give rise to metastasis, suggesting a dormant state in this site. We discovered that dormancy of HNSCC DTCs precedes metastasis and that dormant DTCs are governed by unique chromatin states and microenvironmental cues that can be derived from the vascular niche. Through loss-of-function screens, we also identified chromatin remodelers that enforce tumor cell dormancy. Further, using information we derived from senescence models, we determined that dormant DTCs express chromatin regulators and secreted factors found in senescent cells. We hypothesize that specific microenvironmental cues and epigenetic regulators induce and maintain a strong, yet reversible, growth arrest program during the dormant state of DTCs. We found that the quiescence and differentiation signals, retinoic acid (atRA), TGF2 and BMP7 can induce dormancy and metastasis suppression. Dormant cancer cells also display a global repressive chromatin state and upregulation of specific transcription factors (NR2F1) and histone variants (macroH2A, clipped H3.3), found upregulated during differentiation, senescence and metastasis suppression. In addition, CRISPR-Cas9 screens identified the chromatin remodeler ARID1A as an enforcer of dormancy. We propose that microenvironmental and epigenetic regulators converge to induce and maintain dormancy. We will test this hypothesis by A) investigating the role of histone variant macroH2A associated with quiescence and senescence programs in DTC dormancy induction, B) deciphering how ARID1A enforces dormancy and C) by identifying chromatin permissive states for dormancy induction by microenviromental signals. MPI SYNERGY: The Aguirre-Ghiso and Bernstein labs along with our collaborators have a productive history of publications and active collaborations. This team possesses specialized expertise in dormancy, metastasis, and chromatin biology that has delivered breakthroughs in the cancer dormancy and metastasis fields. The Condeelis team will provide the most advanced intravital imaging to dissect the epigenetic and microenvironmental regulation of DTC dormancy onset and survival at single cell resolution. Importantly, the Klein and Stoecklein labs will allow validation of our findings in human DTC samples. This provides an unsurpassed opportunity to dissect the microenvironmental and epigenetic regulation of single DTC dormancy.
总结:大多数HNSCC患者死于局部复发和/或早期发生的转移, 或原发肿瘤切除后多年。这可能是由于残留的播散性肿瘤细胞(DTC) 潜伏在病人体内DTC可以在骨髓(BM)中检测到,但很少引起转移, 说明这里处于休眠状态我们发现HNSCC DTCs的休眠先于转移 休眠的DTC由独特的染色质状态和微环境线索控制, 源自血管龛。通过功能丧失筛选,我们还确定了染色质重塑 促使肿瘤细胞休眠。此外,利用我们从衰老模型中获得的信息,我们 确定休眠DTC表达染色质调节因子和衰老细胞中发现的分泌因子。 我们假设,特定的微环境线索和表观遗传调节诱导和维持 一个强大的,但可逆的,在DTC的休眠状态生长停滞程序。我们发现 休眠和分化信号,视黄酸(atRA),TGF β 2和BMP 7可以诱导休眠, 转移抑制食管癌细胞还显示出全面的抑制性染色质状态, 特异性转录因子(NR 2F 1)和组蛋白变体(macroH 2A,剪切H3.3)的上调,发现 在分化、衰老和转移抑制期间上调。CRISPR-Cas9 筛选鉴定了染色质重塑剂ARID 1A作为休眠的执行者。我们建议 微环境和表观遗传调节剂会聚以诱导和维持休眠。我们将测试这个 A)研究与静止相关的组蛋白变体macroH 2A的作用, DTC休眠诱导中的衰老程序,B)破译ARID 1A如何强制休眠,以及C) 通过识别微环境信号诱导休眠的染色质允许状态。MPI SYNERGY:Aguirre-Ghiso和伯恩斯坦实验室沿着我们的合作者有着丰富的历史, 出版物和积极合作。这个团队在休眠,转移, 以及在癌症休眠和转移领域取得突破的染色质生物学。的 Condeelis团队将提供最先进的活体成像,以解剖表观遗传和 微环境调节DTC休眠开始和单细胞分辨率的存活。重要的是 Klein和Stoecklein实验室将允许在人类DTC样本中验证我们的发现。这提供了一 无与伦比的机会,解剖微环境和表观遗传调节单一DTC休眠。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julio A. Aguirre-Ghiso其他文献

Models, mechanisms and clinical evidence for cancer dormancy
癌症休眠的模型、机制和临床证据
  • DOI:
    10.1038/nrc2256
  • 发表时间:
    2007-11-01
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Julio A. Aguirre-Ghiso
  • 通讯作者:
    Julio A. Aguirre-Ghiso
Targeting PERK Arm of Unfolded Protein Response Helps to Eliminate Therapy-Induced Residual Senescent-like Acute Myeloid Leukemia Cells
  • DOI:
    10.1182/blood-2024-203451
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Gowri Poigaialwar;Sumiko Takao;Sovira Chaudhry;Laura K. Schmalbrock;Varun Gupta;Alex Kentsis;Julio A. Aguirre-Ghiso;Marina Konopleva;Maria S. Sosa;Anna Skwarska
  • 通讯作者:
    Anna Skwarska

Julio A. Aguirre-Ghiso的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julio A. Aguirre-Ghiso', 18)}}的其他基金

Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
  • 批准号:
    10525056
  • 财政年份:
    2022
  • 资助金额:
    $ 42.81万
  • 项目类别:
Functional Determinants of Metastatic Dormancy
转移休眠的功能决定因素
  • 批准号:
    10428636
  • 财政年份:
    2022
  • 资助金额:
    $ 42.81万
  • 项目类别:
Functional Determinants of Metastatic Dormancy
转移休眠的功能决定因素
  • 批准号:
    10516864
  • 财政年份:
    2022
  • 资助金额:
    $ 42.81万
  • 项目类别:
Functional Determinants of Metastatic Dormancy
转移休眠的功能决定因素
  • 批准号:
    10678829
  • 财政年份:
    2022
  • 资助金额:
    $ 42.81万
  • 项目类别:
Immune Regulation of Disseminated Cancer Cell Dormancy
播散性癌细胞休眠的免疫调节
  • 批准号:
    10201082
  • 财政年份:
    2021
  • 资助金额:
    $ 42.81万
  • 项目类别:
Immune Regulation of Disseminated Cancer Cell Dormancy
播散性癌细胞休眠的免疫调节
  • 批准号:
    10513907
  • 财政年份:
    2021
  • 资助金额:
    $ 42.81万
  • 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
  • 批准号:
    10645058
  • 财政年份:
    2020
  • 资助金额:
    $ 42.81万
  • 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
  • 批准号:
    10226338
  • 财政年份:
    2020
  • 资助金额:
    $ 42.81万
  • 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
  • 批准号:
    10414811
  • 财政年份:
    2020
  • 资助金额:
    $ 42.81万
  • 项目类别:
Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
  • 批准号:
    9924485
  • 财政年份:
    2017
  • 资助金额:
    $ 42.81万
  • 项目类别:

相似国自然基金

层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 批准年份:
    1988
  • 资助金额:
    2.0 万元
  • 项目类别:
    面上项目

相似海外基金

Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
  • 批准号:
    2322614
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
  • 批准号:
    ES/Z50290X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
  • 批准号:
    NE/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
  • 批准号:
    534092360
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Major Research Instrumentation
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
  • 批准号:
    2326714
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
  • 批准号:
    2326713
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
  • 批准号:
    24K20765
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
  • 批准号:
    2427233
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Postdoctoral Fellowship: OPP-PRF: Tracking Long-Term Changes in Lake Area across the Arctic
博士后奖学金:OPP-PRF:追踪北极地区湖泊面积的长期变化
  • 批准号:
    2317873
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
  • 批准号:
    2427232
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了